今日观察！A Wave of "Kete Valuation" Sweeps Through the Market: 50 Stocks Poised for Strong Growth

A Wave of "Kete Valuation" Sweeps Through the Market: 50 Stocks Poised for Strong Growth

Shanghai, China - June 17, 2024 - A recent surge in investor sentiment towards growth stocks, particularly in the healthcare and technology sectors, has been dubbed the "Kete Valuation" phenomenon, named after the Chinese pharmaceutical company C-Bridge (6160.HK). This trend is reminiscent of the "CATL Valuation" rally that occurred in 2021, driven by the strong performance of Contemporary Amperex Technology Co., Ltd. (300015.SZ).

The "Kete Valuation" is characterized by a sharp increase in the share prices of companies with promising growth prospects, often defying broader market trends. This is evident in the recent performance of 50 stocks identified by analysts as having significant growth potential. These stocks, spanning various industries including healthcare, technology, and consumer goods, have exhibited remarkable resilience amidst recent market volatility.

Factors Driving the "Kete Valuation"

Several factors are contributing to the "Kete Valuation" trend. Firstly, investors are increasingly seeking out companies that can deliver sustainable growth, particularly in the face of global economic uncertainties. Secondly, the easing of monetary policy in major economies is providing a supportive backdrop for riskier assets like growth stocks. Additionally, advancements in technology and innovation are creating new opportunities for companies in various sectors, fueling investor optimism.

Key Beneficiaries of the "Kete Valuation"

Among the 50 stocks identified as potential beneficiaries of the "Kete Valuation," C-Bridge (6160.HK) stands out as a frontrunner. The company's innovative cancer therapies and strong pipeline of new drugs have attracted significant investor interest. Other notable stocks include:

• Ascletis Pharma (1672.HK): A clinical-stage biopharmaceutical company developing novel therapies for cancer and viral diseases.

• Aier Eye Hospital Group (300015.SZ): A leading provider of comprehensive eye care services in China.

• Xiaomi Corporation (1810.HK): A global technology company known for its smartphones, smart home devices, and internet services.

Investment Implications

The "Kete Valuation" presents an opportunity for investors to capitalize on the growth potential of select companies. However, careful due diligence is crucial, as not all growth stocks are created equal. Investors should thoroughly evaluate a company's financial health, competitive landscape, and long-term growth prospects before making investment decisions.

The "Kete Valuation" highlights the evolving dynamics of the Chinese stock market, where investors are increasingly discerning and seeking out companies with genuine growth potential. This trend is likely to continue as China's economy transitions towards a more innovation-driven and knowledge-based model.

小米SU7首搭“小爱同学”豆包大模型：智能手机语音交互新时代开启

北京，2024年6月14日 - 今天，小米举行新品发布会，正式发布了旗下全新智能手机SU7。该机的一大亮点是搭载了升级版“小爱同学”AI助手，该版本接入了字节跳动旗下火山引擎的大模型“豆包”。这意味着小米SU7用户将能够体验到更加强大、自然的语音交互功能。

AI赋能，语音交互再升级

“豆包”是字节跳动旗下火山引擎推出的超大规模预训练语言模型，拥有强大的文本理解和生成能力。通过接入“豆包”，小爱同学将能够更好地理解用户的语音指令，并提供更加精准、个性化的回复。

具体来说，在接入“豆包”后，小爱同学将具备以下优势：

• **更强的语义理解能力：**能够更加准确地理解用户语音指令的含义，即使是复杂或多义的指令也能轻松识别。
• **更丰富的知识库：**能够访问“豆包”庞大的知识库，为用户提供更加全面、准确的信息。
• **更自然的语音交互：**能够与用户进行更加自然流畅的对话，并根据上下文进行推理和判断。

小米SU7：AI体验全面升级

小米SU7作为首批搭载升级版“小爱同学”的智能手机，将为用户带来全新的AI体验。用户可以通过语音指令完成各种操作，例如拨打电话、发送短信、设置闹钟、播放音乐、查询天气等。

此外，小米SU7还支持小爱同学的离线语音识别功能，即使在没有网络的情况下也能使用语音指令控制手机。

开启智能手机语音交互新时代

随着人工智能技术的不断发展，语音交互已经成为智能手机的重要人机交互方式之一。小米SU7的发布，标志着智能手机语音交互技术进入了一个新的阶段。

相信在“豆包”大模型的赋能下，小爱同学将能够为用户带来更加智能、便捷的体验，并推动智能手机语音交互技术的进一步发展。

以下是一些关于小爱同学接入豆包大模型的额外信息：

• 小爱同学是小米AI旗下的人工智能语音助手，于2017年正式发布。
• 豆包大模型是字节跳动旗下火山引擎推出的超大规模预训练语言模型，在2022年发布。
• 除了小米SU7之外，火山引擎的大模型服务还将应用于其他智能终端产品，例如OPPO、vivo、荣耀等品牌的手机。

请注意：

• 本新闻稿仅供参考，不构成任何投资建议。
• 本新闻稿中的信息可能存在误差或遗漏，恕不承担任何责任。